IMVT logo

Immunovant (IMVT) Free Cash Flow

Annual FCF

-$214.59 M
-$26.20 M-13.91%

March 31, 2024


Summary


Performance

IMVT Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIMVTcash flowmetrics:

Quarterly FCF

-$100.57 M
-$11.73 M-13.20%

December 31, 2024


Summary


Performance

IMVT Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIMVTcash flowmetrics:

TTM FCF

-$325.64 M
-$53.34 M-19.59%

December 31, 2024


Summary


Performance

IMVT TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIMVTcash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

IMVT Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-13.9%-112.9%-54.7%
3 y3 years-156.9%-214.6%-239.6%
5 y5 years-301.9%--

IMVT Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-156.9%at low-397.5%at low-239.6%at low
5 y5-year-301.9%at low-626.4%at low-2201.9%at low
alltimeall time-301.9%at low<-9999.0%at low<-9999.0%at low

Immunovant Free Cash Flow History

DateAnnualQuarterlyTTM
Dec 2024
-
-$100.57 M(+13.2%)
-$325.64 M(+19.6%)
Sep 2024
-
-$88.84 M(+16.3%)
-$272.30 M(+11.8%)
Jun 2024
-
-$76.38 M(+27.6%)
-$243.55 M(+13.5%)
Mar 2024
-$214.59 M(+13.9%)
-$59.85 M(+26.7%)
-$214.59 M(+1.9%)
Dec 2023
-
-$47.23 M(-21.4%)
-$210.56 M(+0.4%)
Sep 2023
-
-$60.09 M(+26.7%)
-$209.82 M(+23.5%)
Jun 2023
-
-$47.41 M(-15.1%)
-$169.94 M(-9.8%)
Mar 2023
-$188.39 M(+77.1%)
-$55.82 M(+20.1%)
-$188.39 M(+13.7%)
Dec 2022
-
-$46.49 M(+130.0%)
-$165.65 M(+9.6%)
Sep 2022
-
-$20.22 M(-69.3%)
-$151.12 M(+0.1%)
Jun 2022
-
-$65.86 M(+99.1%)
-$151.00 M(+42.0%)
DateAnnualQuarterlyTTM
Mar 2022
-$106.37 M(+27.3%)
-$33.07 M(+3.5%)
-$106.37 M(+10.9%)
Dec 2021
-
-$31.97 M(+59.1%)
-$95.88 M(+10.5%)
Sep 2021
-
-$20.09 M(-5.4%)
-$86.76 M(-4.6%)
Jun 2021
-
-$21.23 M(-6.0%)
-$90.92 M(+8.8%)
Mar 2021
-$83.54 M(+56.5%)
-$22.59 M(-1.1%)
-$83.54 M(+37.1%)
Dec 2020
-
-$22.84 M(-5.8%)
-$60.95 M(+60.0%)
Sep 2020
-
-$24.26 M(+75.2%)
-$38.10 M(+169.3%)
Jun 2020
-
-$13.85 M(+4492.0%)
-$14.15 M(+2558.1%)
Mar 2020
-$53.39 M
-
-
Sep 2019
-
-$301.50 K(+30.9%)
-$532.20 K(+130.7%)
Jun 2019
-
-$230.30 K(>+9900.0%)
-$230.70 K(>+9900.0%)
Mar 2019
-
-$400.00
-$400.00

FAQ

  • What is Immunovant annual free cash flow?
  • What is the all time high annual FCF for Immunovant?
  • What is Immunovant annual FCF year-on-year change?
  • What is Immunovant quarterly free cash flow?
  • What is the all time high quarterly FCF for Immunovant?
  • What is Immunovant quarterly FCF year-on-year change?
  • What is Immunovant TTM free cash flow?
  • What is the all time high TTM FCF for Immunovant?
  • What is Immunovant TTM FCF year-on-year change?

What is Immunovant annual free cash flow?

The current annual FCF of IMVT is -$214.59 M

What is the all time high annual FCF for Immunovant?

Immunovant all-time high annual free cash flow is -$53.39 M

What is Immunovant annual FCF year-on-year change?

Over the past year, IMVT annual free cash flow has changed by -$26.20 M (-13.91%)

What is Immunovant quarterly free cash flow?

The current quarterly FCF of IMVT is -$100.57 M

What is the all time high quarterly FCF for Immunovant?

Immunovant all-time high quarterly free cash flow is -$400.00

What is Immunovant quarterly FCF year-on-year change?

Over the past year, IMVT quarterly free cash flow has changed by -$53.34 M (-112.94%)

What is Immunovant TTM free cash flow?

The current TTM FCF of IMVT is -$325.64 M

What is the all time high TTM FCF for Immunovant?

Immunovant all-time high TTM free cash flow is -$400.00

What is Immunovant TTM FCF year-on-year change?

Over the past year, IMVT TTM free cash flow has changed by -$115.09 M (-54.66%)